Rights and permissions
About this article
Cite this article
The delivery of a pharmaceutical care programme can lead to improvements in symptoms and QOL for patients with heart failure (HF). Pharmacoecon. Outcomes News 487, 13 (2005). https://doi.org/10.2165/00151234-200504870-00035
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504870-00035